Lifeward Ltd. Ordinary Shares (LFWD)

Price$7.00

Value ScoreB

Growth ScoreD

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-7.57%

Price vs S&P 500 (4W)11.20%

VGM Score50.35

Market Capitalization$19.71M

All Metrics

Book Value / Share (Quarterly)$2.26

P/TBV (Annual)0.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)58.72%

Cash Flow / Share (Quarterly)$-5.41

Price vs S&P 500 (YTD)-6.93%

Gross Margin (TTM)33.55%

Net Profit Margin (TTM)-154.15%

EPS (TTM)$-19.67

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-19.67

Revenue Growth (5Y)38.06%

EPS (Annual)$-17.16

ROI (Annual)-177.63%

Gross Margin (Annual)38.25%

Net Profit Margin (5Y Avg)-186.30%

Cash / Share (Quarterly)$4.11

Revenue Growth QoQ (YoY)-22.07%

ROA (Last FY)-86.96%

Revenue Growth TTM (YoY)-42.05%

EBITD / Share (TTM)$-18.51

ROE (5Y Avg)-96.19%

Operating Margin (TTM)-149.51%

Cash Flow / Share (Annual)$-11.05

P/B Ratio3.13x

P/B Ratio (Quarterly)3.99x

Net Income / Employee (Annual)$-245,900

EV / Revenue (TTM)1.06x

Net Interest Coverage (TTM)-116.46x

ROA (TTM)-97.39%

EPS Incl Extra (Annual)$-17.16

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)1.64x

3-Month Avg Trading Volume0.02M

52-Week Price Return-50.95%

Revenue / Employee (TTM)$181,800

Tangible BV / Share (Quarterly)$2.04

P/S Ratio (Annual)0.89x

Asset Turnover (Annual)0.96x

52-Week High$15.00

Operating Margin (5Y Avg)-186.56%

EPS Excl Extra (Annual)$-17.16

CapEx CAGR (5Y)-26.18%

26-Week Price Return0.36%

Quick Ratio (Annual)0.74x

13-Week Price Return17.73%

Total Debt / Equity (Annual)0.33x

Current Ratio (Quarterly)2.40x

Enterprise Value$15.57M

Revenue / Share Growth (5Y)57.63%

Asset Turnover (TTM)0.53x

Revenue / Employee (Annual)$272,000

Inventory Turnover (Annual)2.18x

Pretax Margin (Annual)-90.63%

Cash / Share (Annual)$1.42

3-Month Return Std Dev59.29%

Gross Margin (5Y Avg)37.13%

Net Income / Employee (TTM)$-319,400

ROE (Last FY)-236.85%

Net Interest Coverage (Annual)-22.19x

EPS Basic Excl Extra (Annual)$-17.16

Receivables Turnover (TTM)2.72x

Total Debt / Equity (Quarterly)1.16x

EPS Incl Extra (TTM)$-19.67

Receivables Turnover (Annual)3.63x

ROI (TTM)-196.59%

P/S Ratio (TTM)1.34x

Pretax Margin (5Y Avg)-184.32%

Revenue / Share (Annual)$18.99

Tangible BV / Share (Annual)$25.68

Price vs S&P 500 (52W)-75.31%

Year-to-Date Return1.23%

5-Day Price Return-11.89%

EPS Normalized (Annual)$-17.16

ROA (5Y Avg)-51.34%

Net Profit Margin (Annual)-90.38%

Month-to-Date Return-11.78%

EBITD / Share (Annual)$-16.67

Operating Margin (Annual)-89.29%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-84.35%

LT Debt / Equity (Quarterly)1.16x

EPS Basic Excl Extra (TTM)$-19.67

P/TBV (Quarterly)0.85x

P/B Ratio (Annual)1.25x

Inventory Turnover (TTM)2.03x

Pretax Margin (TTM)-154.60%

Book Value / Share (Annual)$5.52

Price vs S&P 500 (13W)9.48%

Beta0.41x

Revenue / Share (TTM)$9.14

ROE (TTM)-243.14%

52-Week Low$4.14

vGradeB

gGradeD

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-3.13est. -1.28

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.13

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
LFWDLifeward Ltd. Ordinary Shares	B	D	C	$7.00
ISRGIntuitive Surgical Inc.	F	B	C	$422.06
EWEdwards Lifesciences Corp	D	C	C	$85.96
STESTERIS plc	C	B	C	$212.35
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$87.33
ALGNAlign Technology Inc	B	C	C	$167.74
SNNSmith & Nephew plc	B	C	C	$30.61
MSAMine Safety Incorporated	B	C	C	$161.30
ESTAEstablishment Labs Holdings Inc.	F	A	B	$74.31
ENOVEnovis Corporation	B	D	C	$23.78
CDRECadre Holdings, Inc.	C	C	D	$30.01

About

Lifeward Ltd develops and commercializes medical devices for rehabilitation and recovery, including wearable exoskeletons, powered suits, functional electrical stimulation bikes, and anti-gravity systems. The company serves multiple care settings—clinical, home, and community—with operations in the United States, Israel, and Germany.